Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Introduction to Hematological Disorders Publisher



Saleki K1, 2, 3 ; Rezaei N4, 5, 6
Authors

Source: Comprehensive Hematology and Stem Cell Research: Volume 1-5 Published:2024


Abstract

Hematological diseases are pathologies where blood and blood-forming organs are affected. These disorders denote a concerning public health topic in the aging population. Malignant hematological diseases comprise lymphoma, leukemia, myeloma, and malignant immunoproliferative disorders. Non-malignant hematological diseases comprise anemias, sickle cell disease, thalassemia, immunodeficiencies, autoimmune disorders, hemorrhagic disorders, and infection-related conditions. The present chapter provides an up-to-date introduction to epidemiology, clinical and laboratory features, diagnosis, and treatment strategies for a wide range of hematological disorders. We also review trends in immunology and genetics hematological research with emphasis on treatment by stem cells. Finally, directions to advance the field are discussed. © 2024 Elsevier Inc. All rights are reserved.
Related Docs
View other Related Docs
1. Comprehensive Hematology and Stem Cell Research: Volume 1-5, Comprehensive Hematology and Stem Cell Research: Volume 1-5 (2024)
2. Unbalanced T-Cell Subsets in Pediatric Patients With Beta-Thalassemia, Human Immunology (2023)
3. Major Histocompatibility Complex (Mhc) Antigens Polymorphism and Alloimmunization Study in Thalassemia Patients With Febrile Non-Hemolytic Transfusion Reaction (Fnhtr), Transfusion Clinique et Biologique (2023)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (3)
Maryam Behfar (3)
Other Related Docs
4. T Helper 17 and Regulatory T-Cell Profile and Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients With Beta-Thalassemia, Transplant Immunology (2023)
5. Applied Stem Cell Research in Sickle Cell Disease, Comprehensive Hematology and Stem Cell Research: Volume 1-5 (2024)
6. A Literature Review on the Parvovirus B19 Infection in Sickle Cell Anemia and Β-Thalassemia Patients, Tropical Medicine and Health (2020)
7. Regulatory Mutation Study in Cases With Unsolved Hypochromic Microcytic Anemia and Α-Major Regulatory Element Haplotype Analysis in Iran, Hemoglobin (2021)
8. Mir-30A Regulates Γ-Globin Expression in Erythoid Precursors of Intermedia Thalassemia Through Targeting Bcl11a, Molecular Biology Reports (2020)
9. Allogenic Hematopoietic Stem Cell Transplant in Iranian Patients With Congenital Sideroblastic Anemia: A Single-Center Experience, Experimental and Clinical Transplantation (2023)
10. Hsct in Patients With Hemoglobinopathies, Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation (2024)
11. First Report of Pediatric Hematopoietic Stem Cell Transplantation Activities in the Eastern Mediterranean Region From 1984 to 2011: On Behalf of the Pediatric Cancer Working Committee of the Eastern Mediterranean Blood and Marrow Transplantation Group, Bone Marrow Transplantation (2017)
12. Potential Therapeutic Roles of Natural Killer Cells in Acute Myeloid Leukemia: A Systematic Review Study, Clinical and Experimental Medicine (2025)
13. A State-Of-The-Art Review on the Micrornas Roles in Hematopoietic Stem Cell Aging and Longevity, Cell Communication and Signaling (2023)
14. Generation of an in Vitro Model of Β-Thalassemia Using the Crispr/Cas9 Genome Editing System, Journal of Cellular Biochemistry (2020)
15. Hematopoietic Stem Cell Transplantation and Lymphodepletion for the Treatment of Cancer, Cancer Immunology: Bench to Bedside Immunotherapy of Cancers# Second Edition (2020)
16. The Role of Aging and Senescence in Bone Marrow Transplantation Outcome, Advances in Experimental Medicine and Biology (2025)
17. Spotlight on the Impact of Viral Infections on Hematopoietic Stem Cells (Hscs) With a Focus on Covid-19 Effects, Cell Communication and Signaling (2023)
18. Cardiac Considerations in Hematopoietic Stem Cell Transplantation (Hsct) for Transfusion-Dependent Thalassemia: A Review, International Journal of Hematology-Oncology and Stem Cell Research (2025)
19. Stem Cell Transplantation for Diamond–Blackfan Anemia. a Retrospective Study on Behalf of the Severe Aplastic Anemia Working Party of the European Blood and Marrow Transplantation Group (Ebmt), Transplantation and Cellular Therapy (2021)
20. Prevalence of Alloantibodies in Thalassemia Patients and Its Relationship With Age, Gender and Blood Group, Acta Medica Iranica (2023)